Axcan Pharma; the next biochempharma ?? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Axcan Pharma; the next biochempharma ??

AXP 360.73

+0.5%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Phil Cressman who wrote (1)	9/11/1997 12:30:00 AM
From: Marc Fortier	Read Replies (1) of 4

Hi guys, I presently have a very small position in AXP. What convinced me to buy some shares last December was the future acceptance by the FDA of a new medecine (Ursidiol if my memory is good) aimed at curing a rare liver disease. Ursidiol would be what they call an orphan drug, which means that it would be protected against duplication for a longer time than other drugs. The market is not very big (a few hundred millions worldwhile I think) for a drug like this one, but for a small company like AXP it could be extremely profitable. As far as I know, we are still waiting for FDA approval, even though a commitee has strongly recommanded Ursidiol to this instance late last year. Best regards, Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next